0001493152-22-017152.txt : 20220617
0001493152-22-017152.hdr.sgml : 20220617
20220617160549
ACCESSION NUMBER: 0001493152-22-017152
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210825
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Agah Ramtin
CENTRAL INDEX KEY: 0001862617
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40738
FILM NUMBER: 221023778
MAIL ADDRESS:
STREET 1: 4546 EL CAMINO REAL
STREET 2: SUITE 223
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RenovoRx, Inc.
CENTRAL INDEX KEY: 0001574094
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271448452
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 W. SANTA CLARA STREET, SUITE 900
CITY: SAN JOSE
STATE: CA
ZIP: 95110
BUSINESS PHONE: 408-800-2649
MAIL ADDRESS:
STREET 1: 333 W. SANTA CLARA STREET, SUITE 900
CITY: SAN JOSE
STATE: CA
ZIP: 95110
3/A
1
ownership.xml
X0206
3/A
2021-08-25
2021-08-25
0
0001574094
RenovoRx, Inc.
RNXT
0001862617
Agah Ramtin
C/O RENOVORX, INC.
4546 EL CAMINO REAL, SUITE B1
LOS ALTOS,
CA
94022
1
1
1
0
Chief Medical Officer
Convertible Notes
2022-04-30
Common Stock
1295
D
Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, will automatically convert into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.
This report on Form 3/A is filed to include the reported convertible notes in Table 2. Due to an administrative error, the notes were omitted from the Form 3 filed with the SEC on August 25, 2021.
/s/ Ramtin Agah, MD
2022-06-17